Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1204-1211

  Rockenbach, Liliana ^a   Bavaresco, Luci ^a   Fernandes Farias, Patrícia ^a   Cappellari, Angélica Regina ^a   Barrios, Carlos Henrique ^b   Bueno Morrone, Fernanda ^b   Oliveira Battastini, Ana Maria ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bladder cancer; E NTPDases; Ecto 5' nucleotidase; Ectonucleotidases; Purinergic signaling; Quercetin

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; ECTO 5' NUCLEOTIDASE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; HYDROLASE; PURINE NUCLEOTIDE; QUERCETIN; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL; CATABOLISM; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROLYSIS; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLADDER CANCER; E-NTPDASES; ECTO-5′-NUCLEOTIDASE; ECTONUCLEOTIDASES; PURINERGIC SIGNALING; QUERCETIN;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXTRACELLULAR SPACE; GPI-LINKED PROTEINS; HUMANS; HYDROLYSIS; NUCLEOTIDES; QUERCETIN; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84884675679     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.10.009     Document Type: Article

References (36)

1. Shabbir M., Ryten M., Thompson C., et al. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int 2008, 101:106-112.
2. Swellam T., Miyanaga N., Onozawa M., et al. Antineoplastic activity of honey in an experimental bladder cancer implantation model: In vivo and in vitro studies. Int J Urol 2003, 10:213-219.
3. Mori K., Enokida H., Kagara I., et al. CpG hypermethylation of collagen type Iα2 contributes to proliferation and migration activity of human bladder cancer. Int J Oncol 2009, 34:1593-1602.
4. Ma L., Feugang J.M., Konarski P., et al. Growth inhibitory effects of quercetin on bladder cancer cell. Front Biosci 2006, 11:2275-2285.
5. Malaveille C., Hautefeuille A., Pignatelli B., et al. Antimutagenic dietary phenolics as antigenotoxic substances in urothelium of smokers. Mutat Res 1998, 402:219-224.
6. Dozmorov M.G., Kyker K.D., Saban R., et al. Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells. BMC Cancer 2006, 6:12.
7. Burnstock G. Therapeutic potential of purinergic signaling for diseases of the urinary tract. BJU Int 2011, 107:192-204.
8. Burnstock G. Introcduction: P2 receptors. Curr Top Med Chem 2004, 4:793-803.
9. Zimmermann H. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res 2001, 52:44-56.
10. Robson S.C., Sévigny J., Zimmermann H. The ENTPDase family of ectonucleotidases: Structure function relationships and pathophysiologic significance. Purinergic Signal 2006, 2:409-430.
11. Bianchi V., Spychala J. Mammalian 5'-nucleotidases. J Biol Chem 2003, 278:46195-46198.
12. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther 2000, 87:161-173.
13. Bavaresco L., Bernardi A., Braganhol E., et al. The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation. Mol Cell Biochem 2008, 319:61-68.
14. Wang L., Zhou X., Zhou T., et al. Ecto-5'-nucleotidase promotes invasion, migration, and adhesion of human breast cancer cells. J Cancer Res Clin Oncol 2006, 134:365-372.
15. Ujházy P., Berleth E.S., Pietkiewicz J.M., et al. Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance. Int J Cancer 1996, 68:493-500.
16. Stella J., Bavaresco L., Braganhol E., et al. Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol 2010, 28:260-267.
17. Braganhol E., Tamajusuku A.S., Bernardi A., et al. Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line. Biochim Biophys Acta 2007, 1770:1352-1359.
18. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
19. Yang C.S., Landau J.M., Huang M.T., et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001, 21:381-406.
20. Meng X., Maliakal P., Lu H., et al. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 2004, 52:935-942.
21. Jacobsen E.B., Battastini A.M.O. Flavonoids and cancer prevention. Metabólica 2006, 8:38-44.
22. Avila M.A., Cansado J., Harter K.W., et al. Quercetin as a modulator of the cellular neoplastic phenotype. Adv Exp Med Biol 1996, 401:101-110.
23. Kim E.J., Choi C.H., Park J.Y., et al. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res 2008, 33:971-979.
24. 2+-ATPase activity. Anal Biochem 1986, 157:375-380.
25. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
26. Stagg J., Smyth M.J. Review: Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010, 29:5346-5358.
27. Braganhol E., Zamin L.L., Canedo A.D., et al. Anti-proliferative effect of quercetin in human U138MG glioma cell. Anticancer Drugs 2006, 17:663-671.
28. Merighi S., Mirandola P., Varani K., et al. A glance at adenosine receptors: Novel target for antitumor therapy. Pharmacol Ther 2003, 100:31-48.
29. Hugo F., Mazurek S., Zander U., et al. In vitro effect of extracellular AMP on MCF-7 breast cancer cells: Inhibition of glycolysis and cell proliferation. J Cell Physiol 1992, 153:539-549.
30. Mazurek S., Michel A., Eigenbrodt E. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem 1997, 272:4941-4952.
31. Danylova V.M., Andrukhova O.V., Babiǐchuk V.S., et al. Catalytic characteristics of 5'-nucleotidase in the structure of cell membrane rafts in smooth muscles. Ukr Biokhim ZH 2003, 75:71-76.
32. Fujimara Y., Yamad K., Tachibana H. A lipid raft-associated 67 kDa laminin receptor mediates suppressive effect of ephigalocatechin-3-O-gallate on FcepilsonRI expression. Biochem Biophys Res Commun 2005, 336:674-681.
33. Turnay J., Olmo N., Rissi G., et al. 5'-nucleotidase activity in cultured cell lines, effect of different assay conditions and correlation with cell proliferation. In Vitro Cell Dev Biol 1989, 25:1055-1061.
34. Navarro J.M., Olmo N., Turnay J., et al. Ecto-5'-nucleotidase from a human colon adenocarcinoma cell line. Correlation between enzyme activity and levels in intact cells. Mol Cell Biochem 1998, 187:121-131.
35. Sadej R., Spychala J., Skladanowski C. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res 2006, 16:213-222.
36. Kim H., Kang J.W., Lee S., et al. A3 Adenosine receptor antagonist, truncated thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells. Anticancer Res 2010, 30:2823-2830.